BBA
NVAX icon

Baader Bank Aktiengesellschaft’s Novavax NVAX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,052
Closed -$176K – 515
2024
Q2 		$176K Buy
+17,052
New +$172K 0.01% 368

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Baader Bank Aktiengesellschaft's NVAX Position: Q3 2024 in Review

Baader Bank Aktiengesellschaft sold out of Novavax (NVAX) in Q3 2024, closing a stake of 17,052 shares — an estimated $176K sold.

Baader Bank Aktiengesellschaft first reported a position in NVAX in Q2 2024 and held it in 1 quarter. The position peaked at $176K in Q2 2024. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Baader Bank Aktiengesellschaft reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 17,052 Novavax shares in Q3 2024, an estimated $176K.
  • Baader Bank Aktiengesellschaft first reported a position in Novavax in Q2 2024 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Novavax position peaked at $176K in Q2 2024.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2024, filed 29 Oct 2024.